David Ferrera is a medical device engineer, entrepreneur, and inventor based in Lake Forest, California. He leads RC Medical and Sonorous Neuro, focusing on interventional radiology and neurovascular technologies that move from concept to clinic.
A Career Built Where Engineering Meets the Cath Lab
In the specialized world of interventional radiology and neurovascular medicine, the distance between a physician’s idea and a working device can stretch over years. Regulatory pathways, complex materials, and clinical realities all stand between a sketch on a notepad and a tool in a catheter lab. For nearly 30 years, David Ferrera has chosen to live inside that gap.
His work has traced the arc of modern stroke care and interventional innovation, from early roles inside established device manufacturers to founding and guiding companies that went on to be acquired by larger players. Today, as CEO of RC Medical and CEO and Chairman of Sonorous Neuro, he sits at the center of a network of physician-entrepreneurs, engineers, and investors who are trying to turn recurring problems in procedure rooms into new product platforms.
The story did not begin in Southern California, or in a boardroom. It began in a New England mill town with a young plastics engineering student who split time between the lab and the baseball field.
Roots in New England and an Engineer’s Training
Ferrera grew up in Leominster, Massachusetts, and stayed there for three decades. The region’s history of manufacturing and materials work gave real-world context to what he was learning in school. He attended St. Bernard’s Central Catholic High School in nearby Fitchburg, a setting that combined academic expectation with close-knit community ties.
From there he went on to the University of Lowell in Lowell, Massachusetts, now known as UMass Lowell. He earned a Bachelor of Science in Plastics Engineering, a discipline that would prove central to his later work in catheters, coils, and other implantable or navigational tools. While there, he also played baseball for the university, learning how to perform under pressure, rely on teammates, and think several moves ahead.
The combination of technical training and competitive sport created a foundation that would repeat throughout his career. Engineering was not an abstraction. It was a way to solve specific problems, under constraints, with other people depending on the outcome.
Learning the Device Business from the Inside
After university, Ferrera’s early roles placed him inside established medical device organizations. He held engineering and research positions at IMPRA, Inc. in Tempe, Arizona, then part of Bard, and at Boston Scientific in Watertown, Massachusetts. These roles exposed him to the disciplined processes behind product development, clinical research, and regulatory work.
He later joined Micrus Endovascular as co-founder and Director of Technology Development. Micrus focused on endovascular devices and was eventually acquired by Johnson & Johnson, now operating within Cerenovus. He also served as Director of Clinical Research and R&D at Microvention Inc., a company that would become part of Terumo Corporation of Japan.
Each move added new layers. Design and materials science in one role. Clinical study design and outcomes tracking in another. Exposure to global distribution and acquisition processes in others. Over time, a pattern emerges in Ferrera’s trajectory. He gravitates toward places where new technology intersects with unmet clinical need, and he tends to arrive early, before a company becomes a household name in its niche.
Building Companies Around Stroke and Neurovascular Care
By 2007, Ferrera had stepped fully into the role of company builder. At MindFrame Inc. in Irvine, California, he served as Vice President of Product Development and Clinical Research and as General Manager. There he formed and managed the team that developed the company’s first acute stroke mechanical thrombectomy product line. MindFrame was later acquired by Covidien/ev3 Neurovascular, now part of Medtronic Neurovascular.
In 2011, he co-founded Blockade Medical and served as President and Chief Technology Officer. Blockade focused on devices for neurovascular intervention. In 2016, the company was acquired by Balt Extrusion of France, a firm that designs, manufactures, and distributes interventional neuro radiology devices such as catheters, stents, and coils for hemorrhagic and ischemic stroke.
After the acquisition, Ferrera continued to work within the Balt ecosystem, serving as Chief Technology Officer of Balt Global in France and later contributing to Balt USA. These chapters placed him at the helm of teams responsible for global stroke care technologies, bringing together European and American perspectives on device development and deployment.
Across these roles, one consistent element stands out. Ferrera operates at the intersection of engineering detail and strategic direction. He has helped shape product lines, guide clinical research, and position companies for acquisition, all while keeping sight of the patient outcomes that make the work urgent.
A Venture Studio for Physician-Led Ideas
RC Medical represents a natural next step in that evolution. As CEO of this medical device venture studio, Ferrera now focuses on the entire pipeline of product development for the interventional radiology market. The model is straightforward but demanding.
RC Medical funds, designs, develops, and commercializes products in close collaboration with physician-entrepreneurs. The studio works with doctors who encounter repeated problems in the interventional suite and want to turn those frustrations into practical solutions. Rather than simply licensing a concept, RC Medical builds companies around these ideas, providing engineering, regulatory, and commercialization support.
The first wave of new companies to emerge from RC Medical includes Single Pass, Infinity Neuro, and Sonorous NV. Each focuses on product-based solutions intended to improve patient outcomes through more precise, reliable tools. Through these entities, Ferrera brings together the strands of his career: deep technical knowledge, experience in building organizations, and a track record of getting devices from concept to market and, eventually, into the hands of larger strategic partners.
In addition to his role at RC Medical, he serves as CEO and Chairman of Sonorous Neuro, reinforcing his ongoing focus on neurovascular care. This dual leadership further blurs the line between engineer, operator, and strategic advisor.
Board Roles and a Focus on Cardiovascular Health
Ferrera’s influence extends beyond the companies he leads day to day. He holds board positions at several organizations, including Innervate Medical, Vasometrics Medical, Mehana Medical, SAGE Orange County, and Spinal Singularity. He also serves on the board of the American Heart and Stroke Association in Orange County.
These roles keep him close to emerging technologies and community needs. At Innervate, Vasometrics, and Mehana, he contributes as a co-founder, helping to shape early product strategy and organizational direction. At SAGE Orange County and Spinal Singularity, he supports organizations that operate at the intersection of technology, health, and quality of life.
His involvement with the American Heart and Stroke Association is a natural extension of a career in stroke and cardiovascular care. Ferrera chaired the Heart & Stroke Ball in Orange County in both 2020 and 2021, using his network and experience to support fundraising and awareness efforts. The work suggests a view of innovation that does not stop at the device itself but extends to public education, prevention, and community support.
An Inventor with Dozens of Patents and a Book on Ideas
Across these chapters, Ferrera has accumulated more than 80 United States and international patents for medical devices. The number reflects both longevity and focus. From thrombectomy devices to neurovascular tools, the portfolio captures decades of iteration across related problem spaces.
He has also written about what it takes to move ideas through the messy middle of development. His book Innovation in Translation: How Big Ideas Really Happen, published by Advantage Forbes in 2021, looks at how concepts evolve into practical tools. The title aligns closely with his lived experience. For Ferrera, translation is not just linguistic. It is the act of turning a physician’s observation or an engineer’s sketch into something that can pass regulatory scrutiny, survive manufacturing, and actually help a patient in a moment of crisis.
Observers of his career note a few consistent themes. He returns to collaboration with physicians again and again. He seems comfortable with the reality that not every idea works on the first attempt. And he treats acquisitions not as endpoints but as transitions that open space for the next company or platform.
Life Outside the Lab and a Measured View of Risk
For someone so closely identified with high-stakes clinical care, Ferrera’s personal interests are notably grounded. He enjoys travel, wine, golf, ice hockey, and time with his family. The list reflects both motion and balance. Professional life may revolve around stroke care and interventional radiology, but the person behind the titles is more than a set of patents and exits.
He now makes his home in Lake Forest, California, a region with deep ties to the medical device industry. The location keeps him near key partners and institutions, but his early years in Massachusetts remain part of the story. The journey from Leominster and Lowell to Orange County traces not just geography but the evolution of a field. As stroke care moved from limited options toward more sophisticated mechanical and endovascular solutions, Ferrera’s work moved with it.
Colleagues often point to his willingness to treat mistakes as learning tools rather than failures. That stance is particularly important in medical devices, where innovation requires experimentation but the stakes are human lives. The result is a career marked by calculated risks, careful iteration, and a steady focus on patient benefit.
Today, the pressure on healthcare systems, clinicians, and device makers continues to rise. Stroke remains a leading cause of death and disability worldwide. Interventional radiology is expanding into new territories, from oncology to complex vascular work. In that context, Ferrera’s approach offers a specific kind of blueprint.
Stay close to the procedure room. Build with physicians, not just for them. Accept that the path from idea to implementation will be nonlinear, and design organizations that can absorb that reality. Treat exits and acquisitions not only as financial events but as opportunities to recycle talent and insight into the next venture.
If you want to follow his work, you can look to his writing as a Forbes author, his book on innovation, and his many podcast conversations where he reflects on building purpose-driven businesses in the medical device space.
